Skip to main content
Erschienen in: European Journal of Nutrition 8/2008

01.12.2008 | ORIGINAL CONTRIBUTION

B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia

verfasst von: Chien-Hsiung Cheng, Yi-Chia Huang, Feng-Pan Chen, Ming-Chih Chou, Tsung-Po Tsai

Erschienen in: European Journal of Nutrition | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Although fasting and post-methionine loading (PML) homocysteine concentrations are not necessarily related, a high percentage of hyperhomocysteinemia cases would be missed if methionine loading was not performed.

Aim of the study

The influences of B-vitamins and genetic polymorphism (methylenetetrahydrofolate reductase 677C → T, MTHFR 677C → T) on fasting and PML homocysteine concentrations and the relationship between fasting and PML homocysteine were studied.

Methods

This study was a cross-sectional study. Healthy subjects were divided into either fasting hyper-homocysteinemia (≥12.2 µmol/l) (fasting hyper-hcy, n = 51), PML hyper-homocysteinemia (fasting homocysteine <12.2 µmol/l but PML homocysteine ≥25.6 µmol/l) (PML hyper-hcy, n = 29), or normo-homocysteinemia (fasting homocysteine <12.2 µmol/l and PML homocysteine <25.6 µmol/l) (normo-hcy, n = 118) group based on elevated fasting and PML homocysteine levels of the 75th percentile of the population. The concentrations of plasma fasting and PML homocysteine, serum folate, vitamin B-12, plasma pyridoxal 5′- phosphate (PLP) were measured. The genetic polymorphisms were determined.

Results

Fasting homocysteine, but not PML homocysteine and MTHFR 677C → T genotype, was significantly and inversely affected by serum folate concentration after adjusting for potential confounders (β = −0.062, P < 0.01). Fasting and PML homocysteine were highly associated in the fasting hyper-hcy and pooled groups (P < 0.01) but not in the PML hyper-hcy and normo-hcy groups. PML homocysteine did not interact with either serum folate (P = 0.302), vitamin B-12 (P = 0.465), plasma PLP (P = 0.996) or MTHFR 677C → T genotype (P = 0.136) to affect fasting homocysteine concentration.

Conclusions

Approximately one-third (36.3%) of hyperhomocysteinemia cases would be missed if methionine loading were not performed. Even though subjects may have a normal fasting homocysteine concentration, they need further screening for their PML homocysteine.
Literatur
1.
Zurück zum Zitat Araki A, Sako Y (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422: 43–52CrossRef Araki A, Sako Y (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422: 43–52CrossRef
2.
Zurück zum Zitat Bates CJ, Pentieva KD, Matthews N, Macdonald A (1999) A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Chin Chim Acta 280:101–111CrossRef Bates CJ, Pentieva KD, Matthews N, Macdonald A (1999) A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Chin Chim Acta 280:101–111CrossRef
3.
Zurück zum Zitat Bostom AG, Jacques PF, Nadeau MR, Williams RR, Ellison RC, Selhub J (1995) Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis 116:147–51CrossRef Bostom AG, Jacques PF, Nadeau MR, Williams RR, Ellison RC, Selhub J (1995) Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis 116:147–51CrossRef
4.
Zurück zum Zitat Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intake. JAMA 274:1049–1057CrossRef Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intake. JAMA 274:1049–1057CrossRef
5.
Zurück zum Zitat Brattström L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B, Hamfelt A (1990) Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 81:51–60CrossRef Brattström L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B, Hamfelt A (1990) Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 81:51–60CrossRef
6.
Zurück zum Zitat Clarke R, Armitage J (2000) Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 26:341–348CrossRef Clarke R, Armitage J (2000) Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 26:341–348CrossRef
7.
Zurück zum Zitat Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149–1155 Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149–1155
8.
Zurück zum Zitat Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P (1993) Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 13:1253–1260 Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P (1993) Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 13:1253–1260
9.
Zurück zum Zitat Dunkelgrun M, Hoeks SE, Schouten O, Feringa HHH, Welten GMJM, Vidakovic R, van Gestel YRBM, van Domburg RT, Goei D, de Jonge R, Lindemans J, Poldermans D (2008) Methionine loading does not enhance the predictive value of homocysteine serum testing for all-cause mortality or major adverse cardiac events. Intern Med J (in press) Dunkelgrun M, Hoeks SE, Schouten O, Feringa HHH, Welten GMJM, Vidakovic R, van Gestel YRBM, van Domburg RT, Goei D, de Jonge R, Lindemans J, Poldermans D (2008) Methionine loading does not enhance the predictive value of homocysteine serum testing for all-cause mortality or major adverse cardiac events. Intern Med J (in press)
10.
Zurück zum Zitat Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D (2001) Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 81:645–672CrossRef Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D (2001) Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 81:645–672CrossRef
11.
Zurück zum Zitat Girelli D, Martinelli N, Olivieri O, Pizzolo F, Friso S, Faccini G, Bozzini C, Tenuti I, LottoV Villa G, Guarini P, Trabetti E, Pignatti PF, Mazzucco A, Corrocher R (2006) Hyperhomocysteinemia and mortality after coronary artery bypass grafting. Plos One 1:e83CrossRef Girelli D, Martinelli N, Olivieri O, Pizzolo F, Friso S, Faccini G, Bozzini C, Tenuti I, LottoV Villa G, Guarini P, Trabetti E, Pignatti PF, Mazzucco A, Corrocher R (2006) Hyperhomocysteinemia and mortality after coronary artery bypass grafting. Plos One 1:e83CrossRef
12.
Zurück zum Zitat Giusti B, Camacho-Vanegas O, Attanosio M, Comeglio P, Gori AM, Brunelli T, Prisco D, Gensini GF, Abbate R, Pepe G (1999) Microheterogeneity in the distribution of the 844ins68 in the cystathionine β-synthase gene in Italy. Thromb Res 94:249–254CrossRef Giusti B, Camacho-Vanegas O, Attanosio M, Comeglio P, Gori AM, Brunelli T, Prisco D, Gensini GF, Abbate R, Pepe G (1999) Microheterogeneity in the distribution of the 844ins68 in the cystathionine β-synthase gene in Italy. Thromb Res 94:249–254CrossRef
13.
Zurück zum Zitat Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775–1781CrossRef Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775–1781CrossRef
14.
Zurück zum Zitat Hart SR, Mangoni AA, Swift CG, Jackson SH (2006) Effect of methionine loading on pulse wave analysis in elderly volunteers. Postgrad Med J 82:524–527CrossRef Hart SR, Mangoni AA, Swift CG, Jackson SH (2006) Effect of methionine loading on pulse wave analysis in elderly volunteers. Postgrad Med J 82:524–527CrossRef
15.
Zurück zum Zitat Hart SR, Mangoni AA, Swift CG, Jackson SHD (2006) Lack of significant effects of methionine loading on endothelial function in elderly volunteers. Heat Lung Circ 15:358–361CrossRef Hart SR, Mangoni AA, Swift CG, Jackson SHD (2006) Lack of significant effects of methionine loading on endothelial function in elderly volunteers. Heat Lung Circ 15:358–361CrossRef
16.
Zurück zum Zitat Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC (2003) Homocysteine and risk of coronary artery disease: folate is the important determinant of plasma homocysteine concentration. Nutrition 19:577–583CrossRef Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC (2003) Homocysteine and risk of coronary artery disease: folate is the important determinant of plasma homocysteine concentration. Nutrition 19:577–583CrossRef
17.
Zurück zum Zitat Lee BJ, Huang MC, Chung LJ, Cheng CH, Lin KL, Su KH, Huang YC (2004) Folic acid and vitamin B-12 are more effective than vitamin B-6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease. Eur J Clin Nutr 58:481–487CrossRef Lee BJ, Huang MC, Chung LJ, Cheng CH, Lin KL, Su KH, Huang YC (2004) Folic acid and vitamin B-12 are more effective than vitamin B-6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease. Eur J Clin Nutr 58:481–487CrossRef
18.
Zurück zum Zitat Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R (1996) Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94:2410–2416 Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R (1996) Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94:2410–2416
19.
Zurück zum Zitat Malinow MR, Bostom AG, Krauss RM (1999) Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99:178–82 Malinow MR, Bostom AG, Krauss RM (1999) Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99:178–82
20.
Zurück zum Zitat Marcucci R, Giusti B, Betti I, Evangelisti L, Fedi S, Sodi A, Cappelli S, Menchini U, Abbate R, Prisco D (2003) Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 11:7–12CrossRef Marcucci R, Giusti B, Betti I, Evangelisti L, Fedi S, Sodi A, Cappelli S, Menchini U, Abbate R, Prisco D (2003) Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 11:7–12CrossRef
21.
Zurück zum Zitat Miller JW, Nadeau MR, Smith D, Selhub J (1994) Vitamin B–6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr 59:1033–1039 Miller JW, Nadeau MR, Smith D, Selhub J (1994) Vitamin B–6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr 59:1033–1039
22.
Zurück zum Zitat Qujeq D, Omran TS, Hosini L (2001) Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction. Clin Biochem 34:97–101CrossRef Qujeq D, Omran TS, Hosini L (2001) Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction. Clin Biochem 34:97–101CrossRef
23.
Zurück zum Zitat Refsum H, Ueland PM (1998) Recent data are not in conflict with homocysteine as a cardiovascular risk factor. Curr Opin Lipidol 9:533–539CrossRef Refsum H, Ueland PM (1998) Recent data are not in conflict with homocysteine as a cardiovascular risk factor. Curr Opin Lipidol 9:533–539CrossRef
24.
Zurück zum Zitat Refsum H, Ueland PM, Nygrd O, Vollset SE (1998) Homocysteine and cardiovascular disease. Annu Rev Med 49:31–62CrossRef Refsum H, Ueland PM, Nygrd O, Vollset SE (1998) Homocysteine and cardiovascular disease. Annu Rev Med 49:31–62CrossRef
25.
Zurück zum Zitat Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693–2698CrossRef Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693–2698CrossRef
26.
Zurück zum Zitat Selhub J, Miller JW (1992) Hypothesis—the pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55:131–138 Selhub J, Miller JW (1992) Hypothesis—the pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55:131–138
27.
Zurück zum Zitat Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877–881CrossRef Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877–881CrossRef
28.
Zurück zum Zitat Tsai MY, Welge BG, Hanson NQ, Bignell MK, Vessey J, Schwichtenberg K, Yang F, Bullemer FE, Rasmussen R, Graham KJ (1999) Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis 143:163–170CrossRef Tsai MY, Welge BG, Hanson NQ, Bignell MK, Vessey J, Schwichtenberg K, Yang F, Bullemer FE, Rasmussen R, Graham KJ (1999) Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis 143:163–170CrossRef
29.
Zurück zum Zitat Ubbink JB, van der Merwe A, Delport R, Allen RH, Stabler SP, Riezler R, Vermaak WJ (1996) The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest 98:177–184CrossRef Ubbink JB, van der Merwe A, Delport R, Allen RH, Stabler SP, Riezler R, Vermaak WJ (1996) The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest 98:177–184CrossRef
30.
Zurück zum Zitat Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 124:1927–1933 Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 124:1927–1933
31.
Zurück zum Zitat van den Berg M, de Jong SC, Devillé W, Rauwerda JA, Jakobs C, Pals G, Boers GH, Stehouwer CD (1999) Variability of fasting and post-methionine plasma homocysteine levels in normo- and hyperhomocysteinemia individuals. Neth J Med 55:29–38CrossRef van den Berg M, de Jong SC, Devillé W, Rauwerda JA, Jakobs C, Pals G, Boers GH, Stehouwer CD (1999) Variability of fasting and post-methionine plasma homocysteine levels in normo- and hyperhomocysteinemia individuals. Neth J Med 55:29–38CrossRef
32.
Zurück zum Zitat van der Griend R, Haas FJLM, Duran M, Biesma DH, Th Meuwissen OJA, Banga JD (1998) Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med 132:67–72CrossRef van der Griend R, Haas FJLM, Duran M, Biesma DH, Th Meuwissen OJA, Banga JD (1998) Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med 132:67–72CrossRef
33.
Zurück zum Zitat Ventura P, Panini R, Verlato C, Scarpetta G, Salvioli G (2000) Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading. Metab Clin Exp 49:225–228 Ventura P, Panini R, Verlato C, Scarpetta G, Salvioli G (2000) Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading. Metab Clin Exp 49:225–228
34.
Zurück zum Zitat Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, Kruyssen DA (1997) The 677C → T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132:105–113CrossRef Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, Kruyssen DA (1997) The 677C → T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132:105–113CrossRef
35.
Zurück zum Zitat Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamin B6, B12, and folate. Am J Epidemiol 143:845–859 Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamin B6, B12, and folate. Am J Epidemiol 143:845–859
36.
Zurück zum Zitat Zhang G, Dai C (2001) Gene polymorphism of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular disease. Thromb Res 104:187–195CrossRef Zhang G, Dai C (2001) Gene polymorphism of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular disease. Thromb Res 104:187–195CrossRef
Metadaten
Titel
B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia
verfasst von
Chien-Hsiung Cheng
Yi-Chia Huang
Feng-Pan Chen
Ming-Chih Chou
Tsung-Po Tsai
Publikationsdatum
01.12.2008
Verlag
D. Steinkopff-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 8/2008
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-008-0752-5

Weitere Artikel der Ausgabe 8/2008

European Journal of Nutrition 8/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.